Oncology pipeline: Which drugs show real promise?

WEDNESDAY, OCTOBER 22, 2025  |  10:30 AM - 12:30 PM ET

ESMO 2025 is set to deliver the clinical readouts that could reshape the competitive landscape in cancer R&D.

As the European cancer drug scene prepares to unveil its latest pipeline updates, key questions emerge: Which pathways will prove their worth, and what practice-changing data might disrupt current treatment approaches?

Join our post-conference expert panel as we decode the data defining oncology's direction and examine which pipeline assets show promise.

Will we see the next cancer breakthroughs? Find out — sign up now.